These findings prove that the decreased expression of miR-200b may be associated with malignant tumor progression and poor prognosis in patients with gliomas,suggesting the potential role of miR-200b in glioma management.miR-200b may be a novel and valuable signature for predicting the clinical outcome of patients with gliomas.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback